Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01298674
Recruitment Status : Completed
First Posted : February 18, 2011
Last Update Posted : January 5, 2017
Sponsor:
Information provided by (Responsible Party):
Association for Innovation and Biomedical Research on Light and Image

Brief Summary:
This is an epidemiological study to assess the the prevalence of Age-Related Macular (ARM) Degeneration in Portugal.

Condition or disease
Age-Related Macular Degeneration

Layout table for study information
Study Type : Observational
Actual Enrollment : 6023 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Epidemiological Study of the Prevalence of Age-Related Macular Degeneration in Portugal
Study Start Date : August 2009
Actual Primary Completion Date : October 2013
Actual Study Completion Date : October 2013

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. ARM [ Time Frame: 1 month after the screening ]
    Signs of Age-Related Macular Degeneration


Secondary Outcome Measures :
  1. Other ocular disease [ Time Frame: 1 month after screening ]
    Signs of other ocular disease such as: diabetic retinopathy, glaucoma, cataract, etc.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   55 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Participants with 55 or more years-old
Criteria

Inclusion Criteria:

  • Participants with 55 years-old

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01298674


Locations
Layout table for location information
Portugal
Health care units of Lousã and Trevim-Sol
Lousã, Coimbra, Portugal, 3200-201
ARS Centro - Centro de Saúde de Mira
Mira, Portugal
Sponsors and Collaborators
Association for Innovation and Biomedical Research on Light and Image
Investigators
Layout table for investigator information
Study Director: José Cunha-Vaz, MD, PhD Association for Innovation and Biomedical Research on Light and Image
Principal Investigator: Rufino Silva, MD, PhD Association for Innovation and Biomedical Research on Light and Image
Layout table for additonal information
Responsible Party: Association for Innovation and Biomedical Research on Light and Image
ClinicalTrials.gov Identifier: NCT01298674    
Other Study ID Numbers: CC-01-2009
First Posted: February 18, 2011    Key Record Dates
Last Update Posted: January 5, 2017
Last Verified: January 2017
Additional relevant MeSH terms:
Layout table for MeSH terms
Macular Degeneration
Retinal Degeneration
Retinal Diseases
Eye Diseases